|
|
|
|
|
|
|
03.11.25 - 12:36
|
IDEXX Laboratories Announces Third Quarter Results (Business Wire)
|
|
|
Achieves third quarter revenue growth of 13% as reported and 12% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic.
Strong organic revenue growth was supported by IDEXX execution and commercial performance, reflecting benefits from IDEXX's innovation, including over 1,700 IDEXX inVue Dx™ placements.
Delivers EPS of $3.40, an increase of 21% as reported and 15% on a comparable basis, including operating margin expansion of 100 basis points as reported and 120 basis points on a comparable basis.
Increases 2025 revenue guidance to $4,270 million - $4,300 million, an increase of $43 million or ~1% at midpoint, reflecting stronger CAG Diagnostics recurring revenue performance and outlook for higher IDEXX inVue Dx instrument placements and revenues.
Updates outlook for 2025 reported revenue growth of 9.6% - 10.3% and CAG Diagnostics recurring revenue reported growth of 8.3% - 9.0%, with projected 2025 organic revenue growth of 8.8% - 9.5% and CAG Diagnostics recurring r...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.10.25 - 13:03
|
Bonsai Health Names ModMed Veteran Rick Trefzger Chief Revenue Officer (Business Wire)
|
|
|
Former Modernizing Medicine sales leader joins Bonsai to accelerate growth of its agentic AI platform for healthcare practices.SANTA MONICA, Calif.--(BUSINESS WIRE)--Bonsai Health, the agentic AI platform automating complex healthcare workflows, today announced that Rick Trefzger has joined the company as Chief Revenue Officer (CRO).
Trefzger joins Bonsai after nearly 11 years at Modernizing Medicine (ModMed), where he was an early employee and served as vice president of sales, helping scale the company into the leading specialty-specific EHR platform serving dermatology, ophthalmology, orthopedics, gastroenterology, and other core specialties. During his tenure, ModMed grew into one of the most widely adopted specialty technology platforms in the U.S., transforming how medical practices operate and deliver care. He most recently served as vice president of global software sales at IDEXX (Nasdaq: IDXX).
The appointment follows Bonsai's recent $7 million seed raise, led by Bonfire Ventures and Wonder Ven...
|
|
|
|
|
|
|
|
|
08.10.25 - 20:06
|
IDEXX Laboratories to Release 2025 Third Quarter Financial Results (Business Wire)
|
|
|
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Monday, November 3, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2025 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.
The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-330-6730 or 1-213-279-1575 and reference passcode 300701.
About IDEXX Laboratories, Inc.
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolv...
|
|
|
|
|
07.10.25 - 13:09
|
IDEXX Laboratories Elects Karen Peacock to Board of Directors (Business Wire)
|
|
|
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Directors, effective October 6, 2025.
"We are extremely pleased to welcome Karen to the IDEXX Board of Directors," said Lawrence D. Kingsley, the Company's Independent Non-Executive Board Chair. “Karen is a highly accomplished executive with deep B2B, SaaS software and AI experience gained through building and running software and technology companies at various lifecycle stages. We are confident that her extensive professional experience and skills will complement those of our other Board members and contribute to our Board's overall effectiveness."
“IDEXX is leading the way in building advanced diagnostics, software and AI to advance pet healthcare and improve efficiency for veterinary practices, in partnership with our customers,” said Ms. Peacock. “I'm excited to join such an innovati...
|
|
|
|
|
25.09.25 - 08:30
|
Intervacc appoints Anna-Carin Lagerlöf as Sales and Marketing Director (Cision)
|
|
|
The animal health group Intervacc AB (publ) has appointed Anna-Carin Lagerlöf to the newly established role as Sales and Marketing Director. In this position, Anna-Carin will lead the company's continued sales growth, with a particular focus on Strangvac – Intervacc's vaccine against strangles, a common infectious disease in horses. Anna-Carin brings extensive experience from the animal health market and joins Intervacc from IDEXX Laboratories, where she served as Country Manager for the Nordics. She will assume her new role in November and will also become a member of the company's...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
